Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Oct;64(4):769–774. doi: 10.1038/bjc.1991.396

A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party.

N M Bleehen 1, S P Stenning 1
PMCID: PMC1977696  PMID: 1654987

Abstract

A total of 474 adult patients with malignant glioma (astrocytoma) grade 3 or 4 were randomised into an MRC study (BR2) comparing 45 Gy (in 20 fractions over 4 weeks) with 60 Gy (in 30 fractions over 6 weeks) of radiotherapy given post-operatively. Using 2:1 randomisation, 318 patients were allocated the 60 Gy course and 156 the 45 Gy course. Adjuvant chemotherapy was not given. The results show that a 60 Gy course produces a modest lengthening of progression-free and overall survival. They suggest a statistically significant prolongation of median survival from 9 months in the 45 Gy group to 12 months in the 60 Gy group (hazard ratio = 0.75, chi 2 = 7.36, d.f. = 1, P = 0.007). Over 80% of patients reported no morbidity from the radiotherapy, and there was no evidence of increased short-term morbidity in the higher dose group. Late morbidity was not assessed. A prognostic index defined in a previous MRC study was validated in this new cohort. It identifies a group of patients (20% of the total) with a 2 year survival rate of 28% (95% confidence interval 19% to 38%). It was apparent that the survival advantage to the higher dose was maintained even in the poorest prognostic groups defined by this index.

Full text

PDF
769

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CONCANNON J. P., KRAMER S., BERRY R. The extent of intracranial gliomata at autopsy and its relationship to techniques used in radiation therapy of brain tumors. Am J Roentgenol Radium Ther Nucl Med. 1960 Jul;84:99–107. [PubMed] [Google Scholar]
  2. Chang C. H., Horton J., Schoenfeld D., Salazer O., Perez-Tamayo R., Kramer S., Weinstein A., Nelson J. S., Tsukada Y. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer. 1983 Sep 15;52(6):997–1007. doi: 10.1002/1097-0142(19830915)52:6<997::aid-cncr2820520612>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  3. Chilvers C. E., Fayers P. M., Freedman L. S., Greenwood R. M., Machin D., Palmer N., Westlake A. J. Improving the quality of data in randomized clinical trials: the COMPACT computer package. COMPACT Steering Committee. Stat Med. 1988 Nov;7(11):1165–1170. doi: 10.1002/sim.4780071109. [DOI] [PubMed] [Google Scholar]
  4. Chun M., McKeough P., Wu A., Kasdon D., Heros D., Chang H. Interstitial iridium-192 implantation for malignant brain tumours. Part II: Clinical experience. Br J Radiol. 1989 Feb;62(734):158–162. doi: 10.1259/0007-1285-62-734-158. [DOI] [PubMed] [Google Scholar]
  5. Davis L. W. Malignant glioma--a nemesis which requires clinical and basic investigation in radiation oncology. Int J Radiat Oncol Biol Phys. 1989 Jun;16(6):1355–1365. doi: 10.1016/0360-3016(89)90936-x. [DOI] [PubMed] [Google Scholar]
  6. Freedman L. S. Tables of the number of patients required in clinical trials using the logrank test. Stat Med. 1982 Apr-Jun;1(2):121–129. doi: 10.1002/sim.4780010204. [DOI] [PubMed] [Google Scholar]
  7. Green S. B., Byar D. P., Walker M. D., Pistenmaa D. A., Alexander E., Jr, Batzdorf U., Brooks W. H., Hunt W. E., Mealey J., Jr, Odom G. L. Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep. 1983 Feb;67(2):121–132. [PubMed] [Google Scholar]
  8. Halperin E. C., Bentel G., Heinz E. R., Burger P. C. Radiation therapy treatment planning in supratentorial glioblastoma multiforme: an analysis based on post mortem topographic anatomy with CT correlations. Int J Radiat Oncol Biol Phys. 1989 Dec;17(6):1347–1350. doi: 10.1016/0360-3016(89)90548-8. [DOI] [PubMed] [Google Scholar]
  9. Hartmann G. H., Schlegel W., Sturm V., Kober B., Pastyr O., Lorenz W. J. Cerebral radiation surgery using moving field irradiation at a linear accelerator facility. Int J Radiat Oncol Biol Phys. 1985 Jun;11(6):1185–1192. doi: 10.1016/0360-3016(85)90068-9. [DOI] [PubMed] [Google Scholar]
  10. Kumar P. P., Good R. R., Jones E. O., Patil A. A., Leibrock L. G., McComb R. D. Survival of patients with glioblastoma multiforme treated by intraoperative high-activity cobalt 60 endocurietherapy. Cancer. 1989 Oct 1;64(7):1409–1413. doi: 10.1002/1097-0142(19891001)64:7<1409::aid-cncr2820640707>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  11. Leibel S. A., Gutin P. H., Wara W. M., Silver P. S., Larson D. A., Edwards M. S., Lamb S. A., Ham B., Weaver K. A., Barnett C. Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 1989 Dec;17(6):1129–1139. doi: 10.1016/0360-3016(89)90518-x. [DOI] [PubMed] [Google Scholar]
  12. Onoyama Y., Abe M., Yabumoto E., Sakamoto T., Nishidai T. Radiation therapy in the treatment of glioblastoma. AJR Am J Roentgenol. 1976 Mar;126(3):481–492. doi: 10.2214/ajr.126.3.481. [DOI] [PubMed] [Google Scholar]
  13. Rutten E. H., Kazem I., Slooff J. L., Walder A. H. Post operative radiation therapy in the management of brain astrocytomata-retrospective study of 142 patients. Int J Radiat Oncol Biol Phys. 1981 Feb;7(2):191–195. doi: 10.1016/0360-3016(81)90436-3. [DOI] [PubMed] [Google Scholar]
  14. SWEET W. H. The uses of nuclear disintegration in the diagnosis and treatment of brain tumor. N Engl J Med. 1951 Dec 6;245(23):875–878. doi: 10.1056/NEJM195112062452301. [DOI] [PubMed] [Google Scholar]
  15. Salazar O. M., Rubin P., Feldstein M. L., Pizzutiello R. High dose radiation therapy in the treatment of malignant gliomas: final report. Int J Radiat Oncol Biol Phys. 1979 Oct;5(10):1733–1740. doi: 10.1016/0360-3016(79)90554-6. [DOI] [PubMed] [Google Scholar]
  16. Scanlon P. W., Taylor W. F. Radiotherapy of intracranial astrocytomas: analysis of 417 cases treated from 1960 through 1969. Neurosurgery. 1979 Sep;5(3):301–308. [PubMed] [Google Scholar]
  17. Shin K. H., Urtasun R. C., Fulton D., Geggie P. H., Tanasichuk H., Thomas H., Muller P. J., Curry B., Mielke B., Johnson E. Multiple daily fractionated radiation therapy and misonidazole in the management of malignant astrocytoma. A preliminary report. Cancer. 1985 Aug 15;56(4):758–760. doi: 10.1002/1097-0142(19850815)56:4<758::aid-cncr2820560410>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  18. Stenning S. P., Freedman L. S., Bleehen N. M. An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma. Br J Cancer. 1987 Jul;56(1):89–90. doi: 10.1038/bjc.1987.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Tibshirani R. A plain man's guide to the proportional hazards model. Clin Invest Med. 1982;5(1):63–68. [PubMed] [Google Scholar]
  20. Walker M. D., Alexander E., Jr, Hunt W. E., MacCarty C. S., Mahaley M. S., Jr, Mealey J., Jr, Norrell H. A., Owens G., Ransohoff J., Wilson C. B. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg. 1978 Sep;49(3):333–343. doi: 10.3171/jns.1978.49.3.0333. [DOI] [PubMed] [Google Scholar]
  21. Walker M. D., Green S. B., Byar D. P., Alexander E., Jr, Batzdorf U., Brooks W. H., Hunt W. E., MacCarty C. S., Mahaley M. S., Jr, Mealey J., Jr Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med. 1980 Dec 4;303(23):1323–1329. doi: 10.1056/NEJM198012043032303. [DOI] [PubMed] [Google Scholar]
  22. Walker M. D., Strike T. A., Sheline G. E. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys. 1979 Oct;5(10):1725–1731. doi: 10.1016/0360-3016(79)90553-4. [DOI] [PubMed] [Google Scholar]
  23. Wallner K. E., Galicich J. H., Krol G., Arbit E., Malkin M. G. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys. 1989 Jun;16(6):1405–1409. doi: 10.1016/0360-3016(89)90941-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES